Literature DB >> 7350311

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features.

M I Marks, C H Pai, L Lafleur, L Lackman, O Hammerberg.   

Abstract

A prospective study was performed to estimate the frequency of gastroenteritis due to Yersinia enterocolitica in Montreal children and their families. Evidence of bacterial infection was correlated with clinical features and serologic responses. YE was isolated from the stools of 181 (index cases) of 6,364 children with gastroenteritis over a 15-month period; Salmonella was isolated from 280 and Shigella from 68. Median ages were 24, 30, and 41 months, respectively. All but 18 YE isolates were biotype 4, serotype 0:3. YE was not found in the stools of 545 children without gastrointestinal symptoms. Clinical manifestations of the index cases with YE biotype 4, serotype 0:3 (n = 57) included diarrhea (98%), fever (88%), abdominal pain (64.5%), and vomiting (38.5%) with mean durations of 14, 3.9, 7.7, and 2.4 days, respectively. The duration of excretion of YE in the stool ranged from 14 to 97 days (mean 42). Spread of YE occurred in 27 of 57 families studied, involving 15 of 41 children and 19 of 117 adult contacts; approximately one-third of infected contacts developed diarrhea. Agglutination titers of greater than or equal to 200 were demonstrated in all index cases infected with serotype 0:3, with the exception of two very young infants. YE is a frequent cause of bacterial gastroenteritis in Montreal children. The illness is characterized by persistent diarrhea and abdominal pain, prolonged YE excretion in the stools, and moderate communicability.

Entities:  

Mesh:

Year:  1980        PMID: 7350311     DOI: 10.1016/s0022-3476(80)80318-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  39 in total

1.  Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.

Authors:  Shirly Mildiner-Earley; Virginia L Miller
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  The critical role of iron in some clinical infections.

Authors:  J J Bullen; C G Ward; H J Rogers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

3.  Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.

Authors:  G Mazzoleni; D deSa; J Gately; R H Riddell
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

4.  Pediatrics-epitomes of progress: yersinia enteritis in children.

Authors:  G D Overturf
Journal:  West J Med       Date:  1982-04

5.  YspM, a newly identified Ysa type III secreted protein of Yersinia enterocolitica.

Authors:  Sarah E Witowski; Kimberly A Walker; Virginia L Miller
Journal:  J Bacteriol       Date:  2008-09-19       Impact factor: 3.490

6.  Infection with Yersinia enterocolitica in patients with iron overload.

Authors:  H Y Chiu; D M Flynn; A V Hoffbrand; D Politis
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

Review 7.  Bacterial-induced diarrhoea.

Authors:  L Velásquez Jones; R S Rodríguez
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  The pathogenicity of Yersinia enterocolitica strains isolated from various sources in four test systems.

Authors:  F Mosimabale; C L Gyles
Journal:  Can J Comp Med       Date:  1982-01

9.  Acute and chronic gastrointestinal manifestations associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.

Authors:  A Saebø; J Lassen
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

10.  Faecal carriage rate of Yersinia species.

Authors:  A M Lewis; B Chattopadhyay
Journal:  J Hyg (Lond)       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.